Skip to main content
. 2014 Mar 1;88(1):106–118. doi: 10.1016/j.bcp.2013.12.026

Table 3.

Summary of cis-inhibition studies of TC uptake at an incubation time of 30 sec.

Inhibitor (conc.)
SER
RER

Control
+ Inhibitor
Control
+ Inhibitor
pmol/mg protein pmol/mg protein % of control pmol/mg protein pmol/mg protein % of control
E17βG (100 μM) 37 ± 2 20 ± 1*** 53 ± 3 18 ± 3 13 ± 2* 71 ± 3
E3S (100 μM) 33 ± 5 20 ± 4* 60 ± 5 17 ± 4 12 ± 3 71 ± 5
UDPGA (4 mM) 38 ± 2 36 ± 5 94 ± 8 17 ± 3 15 ± 3 88 ± 3
Stx64 (1 μM) 38 ± 3 34 ± 5 90 ± 7 18 ± 2 17 ± 4 94 ± 12
G6P (1 mM) 36 ± 3 32 ± 1 90 ± 5 23 ± 5 21 ± 5 88 ± 7
Vanadate (1 mM) 36 ± 3 33 ± 1 93 ± 5 23 ± 5 21 ± 4 92 ± 5
Vanadate (1 mM) G6P (1 mM) 36 ± 3 32 ± 2 90 ± 5 23 ± 5 20 ± 4 87 ± 9

Data of TC uptake in absence (Control) and presence (+ Inhibitors) of the given inhibitors are given as mean pmol/mg protein ± SD of at least 3 independent experiments using vesicles from different vesicle preparations. Statistically significant difference in uptake rates compared to the control is given in bold. P-values are indicated by asterisks as followed: * for p < 0.05 and *** for p < 0.001.